BioStock Studio: CLS' CEO about Q3 and the road ahead

Report this content

At the end of last week, Lundbased medtech company Clinical Laserthermia Systems, CLS, published its report for the third quarter 2021. The company's CEO Dan Mogren came to BioStock's studio to tell us more about the most important events of the past quarter and what lies ahead for CLS.

Watch the full interview with CLS' CEO Dan Mogren at biostock.se:

https://www.biostock.se/en/2021/11/biostock-studio-cls-ceo-about-q3-and-the-road-ahead/

This is a press release from BioStock - Connecting Innovation & Capitalhttps://www.biostock.se/

Subscribe

Quick facts

BioStock Studio: CLS’ CEO about Q3 and the road ahead
Tweet this